Register now for our upcoming webinar!

The Expressionist team at Genedata is delighted to invite you to the latest in our series of informative webinars on getting the most out of mass spectrometry. Early next month, Dr. Matthias Berg of Novartis will present his knowledge and first-hand experience of using Genedata Expressionist^® for Mass Spectrometry for the Unbiased In-Depth Characterization of CEX Fractions from a Stressed Monoclonal Antibody by Mass Spectrometry.

Register now to participate in this live webinar!

Key learning objectives

• Understand the advantages of time-resolved deconvolution for
  characterization of glycoproteins
• Recognize patterns emerging from enhanced visualization
• Unbiased detection of differences in large peptide mapping data sets

Who should attend

Scientists in the pharmaceutical and biopharmaceutical industries or academia who are involved in the characterization of recombinant glycoproteins by mass spectrometry.

About Dr. Matthias Berg

Dr. Matthias Berg completed his Ph.D. in characterization of MHC class II peptides of the immune system by mass spectrometry in 1997, working in the laboratories of Professor Donald F. Hunt at the University of Virginia, U.S.A., and Professor Howard R. Morris at Imperial College in London, U.K. On completion of his academic studies, Dr. Berg built a career at Amersham Biosciences and the M-Scan group in Switzerland and Germany, rising to Managing Director of the group's German operation. Following the acquisition of M-Scan by SGS in late 2010, Dr. Berg was appointed Laboratory Head of the Mass Spectrometry Laboratory in Late Phase Analytical Development for Biologics at Novartis, where his main interest is in improving MS data evaluation.

With kind regards,

Your Genedata Expressionist Team